Systemic lupus erythematosus and Sjögren's syndrome: Editorial comment

Current Opinion in Rheumatology

Volumn 17, Issue 5, 2005, Pages 511-512

  Tsokos, George C ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; HEPARIN; IMMUNOSUPPRESSIVE AGENT; INTERFERON; INTERLEUKIN 2; RITUXIMAB;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNITY; CELL DIFFERENTIATION; COMPLEMENT ACTIVATION; DISEASE COURSE; DISEASE EXACERBATION; EDITORIAL; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMMUNOPATHOGENESIS; MOLECULAR MIMICRY; NONHUMAN; PRIORITY JOURNAL; REMISSION; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TREATMENT PLANNING;

ANIMALS; AUTOANTIGENS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SJOGREN'S SYNDROME;

EID: 27344449602     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bor.0000174181.93030.59     Document Type: Editorial

References (10)

1. McClain MT, Heinlen LD, Dennis GJ, et al. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 2005; 11:85-89.
2. Krishnan S, Farber DL, Tsokos GC. T cell rewiring in differentiation and disease. J Immunol 2003; 171:3325-3331.
3. Tsokos GC, Magrath IT, Balow JE. EBV induces normal B cell responses but defective suppressor T cell responses in patients with SLE. J Immunol 1983; 131:1797-1801.
4. Gross AJ, Hochberg D, Rand WM, Thorley-Lawson DA. EBV and systemic lupus erythematosus: a new perspective. J Immunol 2005; 174:6599-6607.
5. Means TK, Latz E, Hayashi F, et al. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J Clin Invest 2005; 115:407-417.
6. Anolik JH, Campbell D, Felgar RE, et al. The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus. Arthritis Rheum 2003; 48:455-459.
7. Tsokos GC, Fleming SD. Autoimmunity, complement activation, tissue injury and back. Curr Dir Autoimmun 2004; 7:149-164.
8. Fleming SD, Monestier M, Tsokos GC. Accelerated ischemia/reperfusion- induced injury in autoimmunity-prone mice. J Immunol 2004; 173:4230-4235.
9. Fleming SD, Egan RP, Chai C, et al. Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice. J Immunol 2004; 173:7055-7061.
10. Tsokos GC. Exploring complement activation to develop biomarkers for systemic lupus erythematosus. Arthritis Rheum 2004; 50:3404-3407.